Summary Chronic sinusitis affects more than 31 million people in the United States. It is more prevalent than heart disease and asthma and has a greater impact on patients? quality of life than chronic back pain or congestive heart failure. The majority of patients with chronic sinusitis are treated with oral antibiotics and/or nasal steroids, which can increase the risk of antibiotic resistance and cause unwanted side effects such as epistaxis (nose bleeds), nasal ulcers, and nasal and oral infections. The most effective treatments are Functional Endoscopic Sinus Surgery (FESS) and balloon dilation at high pressures, which are known to cause significant patient discomfort and are conducted in a surgical suite under general anesthesia or IV sedation. Market Segment as follows: By Type Balloon Sinus Dilation No-Balloon Sinus Dilation By Application Physician?s Office Operating Room By Company Acclarent Entellus Medical Medtronic Smith & Nephew, SinuSys Corporation The main contents of the report including: Section 1: Product definition, type and application, global and China market overview; Section 2: Global and China Market competition by company; Section 3: Global and China sales revenue, volume and price by type; Section 4: Global and China sales revenue, volume and price by application; Section 5: China export and import; Section 6: Company information, business overview, sales data and product specifications; Section 7: Industry chain and raw materials; Section 8: SWOT and Porter's Five Forces; Section 9: Conclusion.
Table of Contents 1 Market Overview 1.1 Market Segment Overview 1.1.1 Product Definition 1.1.2 Market by Type 1.1.2.1 Balloon Sinus Dilation 1.1.2.2 No-Balloon Sinus Dilation 1.1.3 Market by Application 1.1.3.1 Physician?s Office 1.1.3.2 Operating Room 1.2 Global and Regional Market Size 1.2.1 Global Overview
